Maryland Charges Insys With Engaging in Deceptive Opioid Scheme

By REUTERS
NYT
Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.
Published date: September 6, 2018 at 08:02PM
Reuters
New York Times article